Mass Tort CTV Advertising: Precision Targeting

Mass tort advertising isn’t personal injury advertising. The audience is narrow. The criteria are specific. The economics demand precision.

The math is straightforward. Mesothelioma produces roughly 3,000 diagnoses per year across 131 million US households. That’s 0.002%. Even if CTV behavioral layers narrow your audience 10x better than broadcast, you’re still delivering 99.98% non-qualifying impressions. Roundup is different. Tens of millions of Americans bought the product. Geographic and purchase-behavior layers can meaningfully concentrate spend toward likely users.

The distinction matters: high-prevalence torts benefit from CTV’s targeting layers. Rare-diagnosis torts benefit from CTV’s attribution loop. Both benefit from CTV over broadcast. The reasons are different. This guide covers how to run mass tort campaigns on connected TV. For a broader look at mass tort advertising strategy, we cover the full landscape.

Why CTV for Mass Tort

The Targeting Problem

Mass tort campaigns need to find specific people. Someone who used a particular product. During a specific timeframe. Who developed a qualifying condition. Sometimes in a particular geography.

Broadcast can’t do that. It reaches everyone watching a program and hopes qualifiers see the ad. Most don’t qualify. You pay anyway.

The CTV Advantage

CTV layers multiple targeting signals to narrow the audience.

Demographics match age cohorts aligned with product usage. Camp Lejeune targets adults 55+ (1953-1987 exposure window). NEC baby formula targets parents 25-45 with premature infants.

Behavioral data identifies likely product users. Roundup campaigns target lawn care purchasers and gardening interests. Hair relaxer cases focus on specific beauty product purchasing patterns.

Geographic targeting zeros in on contamination sites, manufacturing regions, or military bases. PFAS cases target zip codes near contaminated water sources. Camp Lejeune focuses on North Carolina plus veteran-dense markets.

The Efficiency Difference

Campaign Economics

Mass tort advertising is a massive market. Camp Lejeune alone saw over $250 million in TV ad spend, making it the largest mass tort advertising campaign in history. For insight into where $150 million in monthly legal advertising goes, mass tort represents a growing share.

CPM and CPL Benchmarks

Metric	Typical Range
CPM	$30-50
Unqualified CPL	$75-200
Qualified CPL	$200-500
Cost per signed retainer	$800-3,000

What Drives Cost Variation

Case type matters most. High-value cases attract heavy competition and higher costs. Paraquat case acquisition runs around $9,950. Camp Lejeune sits near $6,500. Lower-profile torts cost less.

Case lifecycle follows a predictable curve. Early entry means lower costs with uncertainty about viability. Peak phase means maximum competition and highest CPLs. Late entry can find cheaper inventory as major advertisers exit.

Qualification level affects cost per lead. Raw leads (contact info only, 5-15% meet criteria) cost less per lead but more per qualified case. Pre-qualified leads (basic screening done, 25-40% meet criteria) cost more per lead but less per retainer.

ROI Timeline

Mass tort ROI plays out over years, not months.

Variable	Typical Range
Cost per qualified lead	$200-500
Lead-to-retainer rate	25-50%
Cost per signed case	$500-2,000
Average case value	$30,000-100,000+
Time to resolution	2-5+ years

Targeting Strategies

By Case Type

Case Type	Age Cohort	Behavioral Signals	Geography
Camp Lejeune	55+	Military affinity, veteran indicators	NC + veteran-dense markets
Roundup	40+	Lawn care, gardening, agriculture	National
Talcum Powder	45-75	Decades of usage patterns	National
PFAS/Water	Varies	Contamination-area residents	Radius around sites
NEC Baby Formula	25-45	Recent parents, premature infant indicators	National

Audience Size vs. Precision

Approach	Audience Size	Qualification Rate
Tight (many layers)	50-200K households	High
Moderate (2-3 layers)	500K-2M households	Medium
Broad (1-2 layers)	5M+ households	Low

Start moderate. Optimize based on qualified lead rates. Too tight and you can’t spend the budget. Too broad and you’re back to broadcast-level waste.

First-Party Data

If you have existing claimant profiles, upload CRM data for matching. Build lookalike audiences from your best leads. Exclude already-contacted households. You’ll need 5,000+ records for matching to work.

Case Lifecycle Strategy

Enter during launch or growth. Be cautious at peak. Consider late entry only if costs justify it.

Creative for Mass Tort

Message Structure

Hook: Name the specific product or situation. “Did you use Roundup weed killer?” or “Were you stationed at Camp Lejeune between 1953 and 1987?”

Qualification: Help viewers self-identify. “If you developed non-Hodgkin lymphoma after Roundup exposure…”

Action: Clear next step. “Call now for a free case review.”

What Works

Specific product names. Clear timeframes. Named qualifying conditions. Real urgency if deadlines exist (statute of limitations, filing windows).

What Doesn’t

Vague claims like “Injured by a product?” Fear tactics. Over-promising on results. Misleading urgency with false deadlines. All of these damage credibility and attract unqualified leads.

Compliance

Mass tort advertising faces additional scrutiny. State bar rules apply. FTC guidelines govern claims. Class action advertising rules vary by jurisdiction. Review creative with counsel before airing. Always.

CTV vs. Purchased Leads

Many firms run both. CTV for exclusive, branded leads with higher conversion rates. Purchased leads for volume and scale. CTV leads convert better because the caller already knows your firm from the commercial.

Why Single-Channel Doesn’t Scale

Some mass tort agencies run exclusively on Facebook and Instagram. Social works for lead volume. It doesn’t build the frequency or trust that drives conversion rates up and cost per retainer down.

A claimant who’s seen your firm’s 30-second CTV spot three times before seeing a Facebook ad converts at a measurably higher rate than one who sees the Facebook ad cold. Multi-channel isn’t a luxury. It’s the math.

The firms running CTV alongside social and programmatic display report 30-50% lower cost per acquisition than single-channel buyers. The reason isn’t complicated. Familiarity reduces friction at every step from impression to intake to signed retainer.

Budget Recommendations

Approach	Monthly Budget
Single DMA test	$15-30K
Regional (5-10 DMAs)	$50-100K
National (targeted)	$150-300K
National (scale)	$300K+

Start smaller. Prove the qualified lead rate. Then scale. A $30K single-market test tells you whether CTV works for your case type before committing six figures. For more on CTV costs and budgeting, we cover the full framework.

The Taqtics Approach

We apply our PI methodology to mass tort with one critical difference: tighter qualification targeting and full-funnel attribution.

Multi-channel by default. CTV, programmatic display, audio, and social working together. Not one channel carrying the entire funnel. We track which combination drives the lowest cost per signed retainer.

Custom audiences built on case criteria, not broad demographics. Pharmacy data, condition indicators, geographic exposure layers, and behavioral signals stacked to concentrate spend on likely qualifiers.

Exclusivity. Your audiences aren’t available to competitors on our platform. One firm per market. One firm per tort per DMA.

210 DMAs of competitive data. Before your first campaign runs, you’ll see exactly what competitors spend, where they buy, and what channels they ignore. The gaps in their strategy become your opening.

Compliant creative produced in-house. We understand bar rules and FTC guidelines across all 50 states.

Honest assessment. Not every mass tort makes sense for CTV. Rare-diagnosis torts like mesothelioma benefit from attribution, not targeting precision. High-prevalence torts like Roundup benefit from both. If your tort doesn’t fit, we’ll say so.